share_log

Jin Medical International | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

SEC announcement ·  Feb 2 05:14
Summary by Futu AI
Jin Medical International Ltd., a foreign private issuer, has reported the appointment of Yanru Guo as an independent member of the Board and the chairperson of the audit committee, the compensation committee, and the nominating and corporate governance committee. The appointment was made by the board of directors on January 26, 2024, and took effect on January 30, 2024. Ms. Guo brings a wealth of experience to the role, having served as chief accountant at Shineco, Inc., a Nasdaq-listed company, since March 2014. Her background includes extensive knowledge of US GAAP, IFRS, and CAS, and over a decade of accounting experience in Nasdaq-listed companies. Prior to her current role, she held positions at Beijing Mobile Interactive Co. Ltd and Beijing Pacific Century Info...Show More
Jin Medical International Ltd., a foreign private issuer, has reported the appointment of Yanru Guo as an independent member of the Board and the chairperson of the audit committee, the compensation committee, and the nominating and corporate governance committee. The appointment was made by the board of directors on January 26, 2024, and took effect on January 30, 2024. Ms. Guo brings a wealth of experience to the role, having served as chief accountant at Shineco, Inc., a Nasdaq-listed company, since March 2014. Her background includes extensive knowledge of US GAAP, IFRS, and CAS, and over a decade of accounting experience in Nasdaq-listed companies. Prior to her current role, she held positions at Beijing Mobile Interactive Co. Ltd and Beijing Pacific Century Info-Tech Co., Ltd. Ms. Guo has earned a master's degree in accounting and a bachelor's degree in management and accounting, and holds a CPA Certificate in China. Her appointment satisfies the 'independence' requirements of the Nasdaq listing rule and Rule 10A-3 under the Securities Exchange Act. The formal announcement of her appointment was signed by Erqi Wang on behalf of Jin Medical International Ltd. on February 1, 2024.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.